Upload
jayson-williams
View
227
Download
0
Embed Size (px)
Citation preview
Treatment with HELP-Apheresis Treatment with HELP-Apheresis in Patients Suffering from in Patients Suffering from
Sudden Sensorineural Hearing Loss: Sudden Sensorineural Hearing Loss: A Prospective, Randomized, Controlled StudyA Prospective, Randomized, Controlled Study
Bianchin G, Russi G, Romano N, Fioravanti P.
Otorhinolaryngology Unit , Santa Maria Nuova Hospital, Reggio Emilia, Italy.
Laryngoscope. 2010 Jan 26
Ri 何何何 / VS 何何何
1
ObjectiveObjective
2
SSHL withhigh LDL
HELP-apheresis
Standard treatmen
t
Standard treatmen
t
IntroductionIntroduction Sudden sensorineural hearing loss (SSHL)
◦Mostly unilateral◦NIDCD: idiopathic hearing loss of ≧ 30dB over
≧ 3 contiguous test frequencies occurring within 3 days
Etiology:◦Viral infection?◦Autoimmunologic mechanism?◦Rupture of inner ear membrane?◦Disturbance of cochlear microcirculation
Blood flow ↓ Hyperviscosity: hypercholesteroleamia
3
IntroductionIntroduction
HELP apheresis: heparin induced LDL and fibrinogen precipitation◦ Improve hemorheology in pt with sudden
hearing lossIncreased RBC adhesiveness/aggregation owing to fibrinogen elevation in hypercholesterolaemic
patients and the rationale of fibrinogen-lowering by LDL apheresis. Eur J Clin Inv 2004;34:378-379
◦Circulating adhesion molecules (E-selectin, VCAM-1, VCAM-1) reduced by apheresis
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? Ther Apher Dial 2006;10:282-286
4
IntroductionIntroduction
LDL/fibrinogen apheresis v.s. standard treatment◦ST: prednisolone, hydroxyethyl starch,
pentixifylline◦Outcome: PTA, speech audiometry, tinnitus,
side effect◦Result: NS but better in apheresis group, esp
high LDL Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentrerial. Lancet
2002;360:1811–1817
5
MethodMethod
Pt selection◦Hearing symmetry before SSHL◦ Inclusion:
Acute, one-side SSHL, ≦ 20 days before treatment LDL > 120 mg/dL
◦Exclusion: Hx of hearing loss, Meniere’s dz, dz of middle ear Tumor, heart dz, dialyzed, coagulopathy, allergy to
heparin, severe liver dz
◦Superiority study (difference ≧ 30%)
6
MethodMethod Standard treatment (ST)
◦ Glycerol 500ml IF QD ×10D◦ Dexamethasone 8mg IM QD ×10D
HELP-apheresis◦ 0.55μm plasma filter◦ Mixed with 0.2M Na acetate buffer (pH 4.85)
containing 100 IU/mL heparin◦ LDL and fibrinogen precipitates at pH 5.12◦ 0.4μm polycarbonate filter◦ Anion exchange absorber (remove at least 300000 IU
heparin)◦ Bicarbonate dialysis + ultrafiltration◦ 3L in 2hr, once
7
MethodMethod HELP-apheresis
◦TC -52%, LDL -56%, VLDL -52%, lipoprotein A -55%, TG -50%
◦Fibrinogen -56%, thrombin -55%, VWF -56%, FV -57%, FVII -35%
◦CRP -56%, plasma viscosity -14%, RBC aggregability -60%, thrombocyte aggregability -60%
◦HDL +14%, peripheral muscle oxygenation +33~50%, coronary flow reserve +14%, cerebral CO2 reactivity +14%
8
Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis. Ther
Apher 2001;5:207-211
MethodMethod
Prospective, randomized No placebo apheresis due to ethical
reasons◦Pt and investigators were not blinded◦Audiologists were blinded
9
MethodMethod
Acoustic measurement◦[Pre]: admission day◦[Post]: end of treatment◦[Last]: 10 days after the end of treatment◦Frequencies: 250, 500, 1k, 2k, 4k Hz
Outcome measurement◦Recovery percentage (%)◦Mean tonal threshold percentage (%)◦Decibel recovery (dB)
10
ResultsResults
11
ST HELP-ST
12
• More hearing recovery in HELP-ST group• “Subsided pressure sensation of affected ear after
apheresis”.
13
• HELP-ST group: significant at both [post] and [last] for all frequencies
• 250, 500, 1k Hz > 2k, 4k Hz• NS between [post] and [last].
14
• HELP-ST better than ST• More evident at [post] and 250, 500, 2k Hz.
15
• HELP-ST > ST.
16
• Higher in fibrinogen<320
• Better recovery in fibrinogen <320.
17
• HELP+ST as a choice for SSHL with fibrinogen>320.
18
• HELP-ST better than ST, both period >8 or <8 days.
DiscussionDiscussion
Disturbance of cochlear microcirculation◦Viremia → swelling of capillary endothelial
cell & mild hypercoagulation◦ Increased viscosity → microcirculation↓◦Reduction of fibrinogen → viscosity↓ 20%
Haemorheology in defined dyslipoproteinemias with elevated serum triglyceride concentrations. Atherosclerosis 1995;125:s117.
◦HELP: pronounced improvement in pt with high fibrinogen and LDLFibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre
trial. Lancet 2002;360:1811–1817.
19
DiscussionDiscussion Plasma viscosity
◦ Inversely proportional to blood flow◦Hct, serum viscosity, RBC aggregation, RBC
deformability◦ Low shear stress
↑Plt & macrophage adhesion, ↓NO, ↑plt & endothelial growth factor
Interaction between RBCs◦Attraction: van der Waal force◦Repulsion: negative charge on RBC membrance
Counteract by LDL (30nm), fibrinogen (47nm) HDL (10nm): competition with LDL
20
DiscussionDiscussion HELP-apheresis: heparin for precipitation of
LDL and fibrinogen but totally absorbed later→heparin not affect the outcome
Improvement > 30%◦HELP-ST: 75% [post], 76.4% [last]◦ST: 41.7% [post], 45% [last]
HELP-ST better than ST:◦All frequencies◦ [post] or [last]◦% value or dB value
21
DiscussionDiscussion HELP-ST better than ST
◦No report of adverse reaction or side effect Nausea/vomiting Allergy to heparin Wound infection, bleeding
◦Pt: “I would receive apheresis again if hearing loss recurred”
◦No influence of fibrinogen on outcome Improved Treatment of Sudden Hearing Loss by Specific Fibrinogen Apheresis. J Clin Apheresis
2004;19: 71–78.
Good recovery in both <320 or >320Better in group of >320
22
ConclusionConclusion HELP-apheresis is safe and effective
treatment for SSHL◦Especially high LDL and/or fibrinogen◦No complication◦Pt’s QoL better
(standardized SF36 questionnaire)Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter,
randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 2009;266:943–953.
By studying this dz and its response to new therapeutic approaches, we are able to gain insight into pathophysiology of inner ear
23